Beta-Cell Function and Sitagliptin Trial (BEST)
clinical trial
Press Enter · cited answer in seconds
0 sources
Beta-Cell Function and Sitagliptin Trial (BEST)
Summary
Beta-Cell Function and Sitagliptin Trial (BEST) is a clinical trial[1].
Key Facts
- Beta-Cell Function and Sitagliptin Trial (BEST) is in the country of Canada[2].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s instance of is recorded as clinical trial[3].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s start time is recorded as +2007-01-31T00:00:00Z[4].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s end time is recorded as +2009-09-30T00:00:00Z[5].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s main subject is recorded as diabetes[6].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s number of participants is recorded as {'unit': '1', 'amount': '+21'}[7].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s title is recorded as A Randomized Controlled Pilot Study Assessing the Effect of Sitagliptin on the Preservation of Beta-Cell Function in Patients With Type 2 Diabetes[8].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s short name is recorded as BEST[9].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+30'}[10].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s ClinicalTrials.gov ID is recorded as NCT00420511[11].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[12].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s research intervention is recorded as metformin[13].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s research intervention is recorded as sitagliptin phosphate[14].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s clinical trial phase is recorded as phase II clinical trial[15].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s research subject recruitment status is recorded as completed[16].
- Beta-Cell Function and Sitagliptin Trial (BEST)'s study type is recorded as interventional study[17].